Study to Determine the Feasibility of Using an At-home Foot Temperature Monitoring Device (Thermidas)
NCT ID: NCT06032221
Last Updated: 2025-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
15 participants
INTERVENTIONAL
2023-07-14
2025-02-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will be provided with an infrared camera and SMART phone and trained in how to use them. The participants will then be expected to capture images of both the plantar and dorsal aspects of their feet that will be sent to the research team for review. The two images will be captured once per day. The Intervention period will be 12 weeks.
If a raised temperature is identified, the participant will be offered a face to face review appointment where they will receive podiatry treatment (if required), ulcer prevention advice and more detailed thermal imaging. Patient and health care professional (HCP) questionnaires will be used at the start and end of the study period to assess quality of life impact and device ease of use.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Remote Foot Temperature Monitoring
NCT04345016
Thales Thermography Triage (3T) - Pilot Project
NCT04792450
Effectiveness of Remote Foot Temperature Monitoring
NCT05728411
The Clinical Performance Validation of Electronic Thermometer and Infrared Thermometers
NCT06353490
Pill Study Hyperthermia Device (Heckel HT 3000): Monitoring Core Body Temperature Using Wireless Technology
NCT02340377
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
device feasibility
All participants issued with Thermidas device
Thermidas Vista Telehealth App
Thermal camera with telemedicine app
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thermidas Vista Telehealth App
Thermal camera with telemedicine app
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or Female \>/ = 18 years of age
* Diabetes Mellitus type 1 or 2 according to WHO criteria
* independently ambulatory
* deemed high risk/ in remission via SCI diabetes foot risk stratification tool
* expected to comply with study schedule
Exclusion Criteria
* active Charcot Neuro-osteoarthropathy
* active foot infection based on PEDIS classification criteria
* amputation proximal to the Chopart joint in one or both feet
* critical limb ischaemia (according to PEDIS classification)
* severe illness that would make 6-month survival unlikely based on the clinical judgement of the physician or podiatrist
* concomitant severe physical or mental conditions that limit the ability to follow the instructions of the study, based on the clinical judgement of the physician or podiatrist
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Robertson Centre for Biostatistics
UNKNOWN
NHS Greater Glasgow and Clyde
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Elizabeth University Hospital
Glasgow, Glasgow, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INGN21DI185
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.